| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 643006 | Null | 0.0183522248172065 | -0.073560171 |
| NSC 649307 | Null | 0.0183522248172065 | 0.16593238 |
| NSC 668476 | Null | 0.0183522248172065 | 0.058485762 |
| NSC 672453 | Null | 0.0183522248172065 | 0.23749832 |
| NSC 676779 | Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop | 0.0183522248172065 | 0.14102246 |
| NSC 681645 | Camptothecin Derivative | 0.0183522248172065 | 0.0068193671 |
| NSC 688021 | Phosphorodiamidic acid, N,N-bis(2-bromoethyl)-, (5-nitro-2-thienyl)methyl ester | 0.0183522248172065 | -0.11100362 |
| NSC 690270 | ANTINEOPLASTIC-690270 | 0.0183522248172065 | 0.028802346 |
| NSC 696127 | Null | 0.0183522248172068 | -0.11018937 |
| NSC 701373 | 3-Pyridinecarbonitrile, 6-[4-[(7-chloro-4-quinolinyl)amino]phenyl]-1,2-dihydro- 4-(4-methoxy-1-naphthalenyl)-2-oxo- | 0.0183522248172068 | 0.0048019044 |